Drug Interaction Briefs in Under 30 Seconds
PolypharmIQ AI generates pre-consultation cascade briefs and optimal MTM engagement sequencing for your complex multi-prescription patients — no more manual chart review.
$pip install polypharmiq Cascade in Seconds
Stop spending 8-12 minutes per patient digging through interaction databases. PolypharmIQ ingests your patient medication list and outputs a ranked cascade of interaction risks with severity scores in under 30 seconds.
- Multi-prescription pathway analysis
- Severity-ranked risk cascade
- Cited interaction evidence
```python
from polypharmiq import CascadeBrief
patient = patient_profile_ingestion(canonical_nabp)
brief = CascadeBrief.generate(
patient,
medications=current_regimen,
include_seq=true
)
print(brief.ranked_risks)
```Engagement Sequencing
Not all interventions are equal. Our sequencing module ranks which drug therapy problems to address first based on cascade severity, patient adherence probability, and time-to-outcome impact — so you focus where it counts.
- Ranked by clinical impact
- Patient adherence weighting
- Time-to-outcome scoring
```python
seq = EngagementSequence.optimize(
brief.risks,
patient.socioeconomic_profile,
consultation_window=20 # minutes
)
print(seq.priority_order)
```PARS-Aligned Output
Every brief includes structured documentation mapped to CMS PARS requirements, giving you audit-ready records without the copy-paste grind. Built for the 1-5 pharmacist operation that can't afford compliance gaps.
- PARS documentation mapping
- Audit-ready format
- No PHI retention
```bash
polypharmiq generate --patient-id XXXX \
--output-format cms-pars \
--dry-run # Preview before commit
```Common Questions
How does PolypharmIQ handle FDA CDS carve-out compliance?
PolypharmIQ is designed as a documentation and sequencing aid — not a diagnostic device. We position under the FDA's CDS carve-out, which excludes software that merely organizes evidence without making clinical recommendations. We recommend a $500 consultation with a healthcare regulatory attorney to validate this positioning for your specific practice context before you go live.
What data does PolypharmIQ send to your servers?
None. Our MVP runs entirely client-side — medication data is processed locally and never leaves your network. You control the data boundary. For practices with strict network policies, we support air-gapped deployment. Your patient PHI stays under your roof.
Does this work with my existing MTM workflow?
PolypharmIQ outputs a ranked cascade brief and engagement sequence — you decide how to integrate it into your current intake process. It doesn't replace your clinical judgment; it removes the manual research overhead so you can spend your time on the patient conversation, not the chart review.
How do you handle edge cases like off-label interactions?
The cascade includes provenance for every interaction cited — including off-label references. If an interaction lacks sufficient evidence for automated ranking, the brief flags it as 'requires pharmacist assessment' rather than force-ranking it. You always get a human-in-the-loop signal before any cascade is finalized.
What independent pharmacy sizes is this built for?
The sweet spot is 1-5 pharmacists managing 20-200 active MTM patients per month. If you're doing fewer than 10 MTM consultations monthly, the workflow overhead may not justify it. If you're a chain or health system, talk to us about enterprise licensing — the architecture scales, but the pricing doesn't fit that segment.
Can I run this before a legal review?
Yes. You can generate sample briefs using synthetic patient data to evaluate the workflow without touching real PHI. This lets you stress-test the output quality and integration fit while your attorney review proceeds in parallel. No commitment required to start evaluating.
Ready to compress your MTM intake?
Run your first patient through the pipeline before you commit. Synthetic data, no PHI, no setup fee.